학술논문
A novel, oral 5HT3 partial agonist, DDP733, improves overall response in patients with irritable bowel syndrome and constipation (IBS-c): A randomized, double blind, placebo-controlled, parallel-group, dose-ranging study
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
00165085